A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
Clinical trial NCT06619561 · RECRUITING
Trial details
- NCT number
- NCT06619561
- Sponsor
- Deciphera Pharmaceuticals, LLC
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-21
- Primary completion
- 2029-10-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.